04/12/2021 Pre Market Brief: Weekend News Edition

You can support the author of this blog by subscribing to Webull and beginning your trading journey with a successful deposit of $100. CLICK HERE (Trade from 4:00 AM to 8:00 PM Eastern). Or you can donate HERE.

Join 231 other subscribers

News that happened while the market was closed. Register your email above or follow on Twitter to receive this report every morning. Understand that this is aimed to help you but you are ultimately responsible for verifying the veracity and timing of the information below.

Published 3:45 AM / Updated 3:45 AM 

1) MARKET FUTURES:

2) FRIDAY 04/09/2021 MARKET RECAP:

3) ECONOMIC CALENDAR MONDAY 04/12/2021:

4) NEWS From Friday 04/09/2021 8:00 PM to Monday 04/12/2021 4:00 AM:

STOCKS

(Stock News Possibly Yet to be Traded 8:00 PM Friday – 4:00 AM Monday EST)

  • BINV BioInvent’s partner Oncurious NV presents Phase I data on TB-403 in pediatric cancer
  • MSFT NUAN Microsoft in advanced talks to buy Nuance for about $16 billion, announcement could come Monday
  • REGN Phase 3 Treatment Trial in Recently Infected Asymptomatic Patients Showed REGEN-COV™ (casirivimab with imdevimab) Significantly Reduced Progression to Symptomatic COVID-19
  • REGN Phase 3 Prevention Trial Showed 81% Reduced Risk of Symptomatic SARS-CoV-2 Infections with Subcutaneous Administration of REGEN-COV™ (casirivimab with imdevimab)
  • DBD Diebold Nixdorf Wins Red Dot Product Design Award for its Retail Self-Service Solution
  • WKEY WISeKey Increases its Semiconductor Manufacturing Capabilities to Support Exploding Demand
  • BGNE MRTX BeiGene’s tislelizumab combo study shows antitumor activity in solid tumors
  • MRTX Mirati Therapeutics Presents Preclinical Data on Novel Approach to PRMT5 Inhibition that Selectively Targets the PRMT5/MTA Complex in MTAP-Deleted Cancer Models
  • BGNE BeiGene Presents Clinical Data on Sitravatinib in Combination with Tislelizumab at the AACR Annual Meeting 2021
  • CMPI Checkmate Pharmaceuticals Presents New Clinical Trial Translational Data with Vidutolimod at the 2021 American Association for Cancer (AACR) Annual Meeting
  • XOM Exxon considers closing Norway oil refinery
  • AAPL Apple Facing Supply Shortage of Upcoming High-End IPad Display
  • IR Ingersoll to Sell Golf Cart Unit for $1.7 Billion, Reuters Says
  • WWE SUNDAY WRESTLEMANIA® SOLD OUT
  • BABA Alibaba Hit With Record $2.8 Billion Antitrust Fine in China
  • BABA Alibaba Says Unaware of Other Probes Under Anti-Monopoly Law
  • BABA China’s Record Alibaba Fine Shows Big Tech Can’t Fight Back
  • EQBK Equity Bancshares Will Announce First Quarter 2021 Results on April 20, 2021
  • HRC Hillrom Comments on Recent Novitas Reimbursement Update
  • HOG Harley-Davidson Nominates Ford CEO Farley to Join Its Board
  • PFE Covid variant from South Africa was able to ‘break through’ Pfizer vaccine in Israeli study
  • DSRLF LMNX DiaSori agreed to to acquire Luminex for $1.8B
  • LYRA Lyra Therapeutics Presents Positive Full Data Set from LANTERN Phase 2 Study of LYR-210 at COSM 2021 Virtual
  • APHA TLRY Aphria Tilray merger to capitalize on changing legal landscape for cannabis use in the U.S.
  • VOW3-DE Biden declares South Korean battery maker deal a win for U.S. electric vehicle production
  • ALNY Alnylam Presents Positive Late-Breaking Data from Ongoing Phase 1 Study of ALN-AGT, an Investigational RNAi Therapeutic for the Treatment of Hypertension
  • CLVS Clovis Oncology’s Rubraca shows promise for prostate cancer in phase 1 trial
  • Lifshitz Law Firm, P.C. Announces Investigation of AEGN, COHR, KSHB, GNLN, KSU, CP, LEAF, MLND, MSGN, MSGE, and TPCO
  • GLSI Greenwich LifeSciences Presents Immune Response Phase IIb Poster, Published at AACR 2021, Showing Peak Immunity after 6 Months of GP2 Treatment, Resulting in 100% Disease Free Survival from Recu..
  • CCCC C4 Therapeutics Presents Preclinical Data on CFT7455 at the AACR Annual Meeting 2021
  • IRTC iRhythm® Technologies Announces Conference Call to Discuss Medicare Administrative Contractor Novitas’s Updated Rate Publication
  • T CSCMA Godzilla vs. Kong’ tops $60 million domestically, the best box office haul of the pandemic
  • PMVP PMV Pharma Presents Late-Breaking Preclinical Data on Lead Product Candidate PC14586 at the American Association for Cancer Research Annual Meeting 2021
  • ZNTL Zentalis Pharmaceuticals Announces Promising Initial Data Presented in a Late-Breaking Session at AACR on ZN-c3, its WEE1 Inhibitor, in Patients with Advanced Solid Tumors
  • JNJ Why Authorities Are Putting The Brakes on Johnson & Johnson’s Vaccine In Several States
  • SYBX Synlogic Presents Data from SYNB1891 Phase 1 Trial at American Association for Cancer Research Annual Meeting
  • GRCL Gracell Biotechnologies Reports Long-term Follow-up Data on TruUCAR-enabled GC027 in Relapsed/Refractory T-ALL at the AACR 2021 Annual Meeting
  • MRSN Mersana Therapeutics Presents Preclinical Data Highlighting Potential of XMT-2056 and XMT-1660 in Three Posters at Virtual 2021 AACR Annual Meeting
  • FUSN Fusion Pharmaceuticals Announces Preclinical Combination Data Demonstrating Enhanced Efficacy in Multiple Preclinical Tumor Models
  • GH Data at AACR Demonstrate Growing Clinical Utility of Guardant Health Liquid Biopsies in the Treatment and Management of Advanced Cancers
  • ARCUS Arcus Biosciences Presents Updated Data for Etrumadenant in Third-Line Metastatic Colorectal Cancer and New Data on its HIF-2α Program at the AACR 2021 Annual Meeting
  • KRON Kronos Bio Presents Preclinical Data for Oral CDK9 Inhibitor KB-0742 Demonstrating Sustained Inhibition of Tumor Growth in Multiple Cancers at AACR Annual Meeting 2021
  • HARP Harpoon Therapeutics Announces Data from Poster Presentations at the AACR Annual Meeting 2021
  • ITOS iTeos Therapeutics Announces New Preliminary Data Indicating Clinical Activity with its Anti-TIGIT Antibody, EOS-448, at the AACR Annual Meeting 2021
  • BDTX Black Diamond Therapeutics Announces Preclinical Data Presentations on BDTX-189 and BDTX-1535 at American Association for Cancer Research Annual Meeting
  • BGNX MacroGenics Announces Presentations at the 2021 AACR Annual Meeting
  • HOOK HOOKIPA announces positive preliminary Phase 1 immunogenicity data for its immunotherapy candidates to treat advanced HPV16+ cancers
  • KYMR Kymera Therapeutics Presents Late-Breaking Preclinical Data Highlighting Superiority of Dual-Targeting Activity of IRAKIMiD Degrader KT-413 at AACR Annual Meeting 2021
  • ALLO Allogene Therapeutics Presents Preclinical Research Highlighting a Novel TurboCAR™ T Cell Technology Designed to Overcome Immune Suppression in Solid Tumors at the American Association for Cancer Research (AACR) Virtual 2021 Meeting
  • BOLT Bolt Biotherapeutics Announces AACR 2021 Presentation of Boltbody™ Platform Mechanism of Action and Clinical Properties of Lead ISAC, BDC-1001
  • TCRR TCR² Highlights Gavo-cel Translational Data and Emerging Solid Tumor Pipeline Preclinical Data at AACR Annual Meeting
  • JNJ Why Authorities Are Putting The Brakes on Johnson & Johnson’s Vaccine In Several States
  • MRSN Mersana Therapeutics Presents Preclinical Data Highlighting Potential of XMT-2056 and XMT-1660 in Three Posters at Virtual 2021 AACR Annual Meeting
  • FUSN Fusion Pharmaceuticals Announces Preclinical Combination Data Demonstrating Enhanced Efficacy in Multiple Preclinical Tumor Models
  • CRSP CRISPR Therapeutics Presents Preclinical Data at AACR 2021 Supporting CD70 Knockout as a Novel Approach to Increasing CAR-T Cell Function
  • JNCE Jounce Therapeutics Presents Preclinical Data from JTX-8064/LILRB2 Program at the 2021 American Association for Cancer Research Virtual Annual Meeting
  • VINC Vincerx Pharma Presents Preclinical Data on VIP236, its Lead Small Molecule Drug Conjugate, at the American Association for Cancer Research Annual Meeting 2021
  • CDAK Codiak Presents Data at AACR 2021 Demonstrating Potential of Engineered Exosomes to Enhance the Therapeutic Index of Well-Validated Cancer Immunotherapy Pathways
  • NXTC NextCure Presents Preclinical Data for NC762 at American Association for Cancer Research Annual Meeting 2021
  • ACHL Achilles Therapeutics Demonstrates cNeT Product Characterization and Post-Infusion Tracking in a Patient Case Study at the American Association for Cancer Research 2021 Annual Meeting
  • ZYME Zymeworks Showcases Preclinical Assets, Including New Therapeutic Platform, ProTECT™, and Zanidatamab Mechanisms of Action at AACR Annual Meeting
  • BCYC Bicycle Therapeutics Announces Presentations at the AACR Annual Meeting 2021
  • IMGN ImmunoGen Presents Preclinical Data on IMGC936 at the AACR Virtual Annual Meeting
  • SRRK Scholar Rock Presents Biomarker Strategy to Support the SRK-181 DRAGON Phase 1 Proof-of-Concept Trial at the American Association for Cancer Research Annual Meeting

(Stock News from 4:00 PM Friday – 8:00 PM Friday EST)

  • CCJ Cameco to restart Cigar Lake uranium mine in northern Sask
  • VZ Proposed Transfer of Control of Tracfone Wireless to Verizon Communications
  • SJM The J. M. Smucker Issues, Voluntary Recall of Two Lots of Meow Mix® Original Choice Dry Cat Food for Potential Salmonella Contamination
  • POST Cereal giant Post Holdings quietly cuts SPAC IPO’s size
  • RLGT Radiant Logistics Recognized By Transport Topics

PENNY STOCKS

  • OCX Oncocyte’s DetermaIO shows correlation with immunotherapy response in bladder cancer (Breaking Over the Weekend)
  • EGY VAALCO Board Member George Maxwell Named Chief Executive Officer and Company Updates Strategic Focus (Breaking Over the Weekend)
  • PIRS Pieris Pharmaceuticals Presents Updated Phase 1 Monotherapy Data for 4-1BB/HER2 Bispecific Cinrebafusp Alfa and Preclinical Data for 4-1BB/PD-L1 Bispecific PRS-344/S095012 at 2021 AACR Annual Me.. (Breaking Over the Weekend)
  • TXTX Theratechnologies Presents New In Vivo Pre-Clinical Data at AACR Demonstrating Significant Anti-Tumor Activity of TH1902 in All Studied Cancer Types (Breaking Over the Weekend)
  • GLYC GlycoMimetics to Present at AACR 2021 Meeting on Positive Therapeutic Effects of GMI-1757 in a Pancreatic Adenocarcinoma Model (Breaking Over the Weekend)
  • ADXS Advaxis Presents Translational Biomarker Data from Ongoing ADXS-503 Phase 1/2 Lung Cancer Trial at the American Associated for Cancer Research 2021 Annual Meeting (Breaking Over the Weekend)
  • NCNA NuCana Announces Five Poster Presentations at the American Association for Cancer Research Annual Meeting 2021(Breaking Over the Weekend)
  • GNCA Genocea to Present Novel Preclinical Inhibigen™ Data at AACR Annual Meeting 2021(Breaking Over the Weekend)
  • AGEN Agenus presents new clinical responses for AGEN1181 at AACR (Breaking Over the Weekend)
  • KZR Kezar Life Sciences Presents Preclinical Data with IND Candidate KZR-261 at American Association for Cancer Research 2021 Virtual Annual Meeting (Breaking Over the Weekend)
  • WLDF Form 8-K: Litigation Complaint Filed on April 9, 2021 Against Convertible Debt Funder On April 9, 2021, we filed a $5,000,000 complaint in The United States District Court for the Southern Distr

INSIDER TRADING ACTIVITY

  • COMP NPA ASTS COUR NSCO The Past Week’s Notable Insider Buys Included Biotechs, Public Offerings, A SPAC And More

—STOCK UPGRADES & DOWNGRADES

—OFFERINGS/SHELF REGISTRATION/FINANCING

  • KREF KKR Real Estate Finance Trust Announces Pricing of Public Offering of 6.50% Series A Cumulative Redeemable Preferred Stock
  • ACM AECOM announced that, in connection with its previously announced tender offer to purchase for cash certain of its 5.875% Senior Notes due 2024, it is increasing the Aggregate Maximum P
  • FIXX Form 8-K: On April 6, 2021, Homology Medicines entered into an underwriting agreement with BTIG, as underwriter, in connection with the public offering, issuance and sale by the Company of 6,596
  • LTBR Form 8-K: Entry into a Material Definitive Agreement On April 9, 2021, the Company entered into an amendment to its at-the-market equity offering sales agreement, dated May 28, 2019 with Stifel

5) POSSIBLE DIP BUYING OPPORTUNITIES:

6) OTHER NEWS

7) UPCOMING EARNINGS:

8) DIVIDEND CALENDAR

I provide this information for free. But if you like this information and wish to help me out, Join Webull, make a $100 deposit, and receive two free stocks. You can also make a one time donation.Image-1

WEBULL Trades from 4:00 a.m. to 8:00 p.m. (eastern) [Be the first to react to overnight news. I cant tell you how many times extended trading hours got me out of a jam or afforded me the opportunity to take advantage of overnight news]
  • Commission Free Trades
  • Commission Free Options
  • Commission Free Shorting on the Most Liquid Securities
  • Free Stocks for Joining and Depositing
  • Built in Forum and News Feed
  • Lend your Long Shares to Shorts for Passive Profit
  • Great Charting and Analysis Tools
  • Built in Stock Screener
  • Transfer is Easy. If your Funds and Stocks are Settled you can Transfer Easily from one Broker to the Next.
  • Transfer reimbursement (Up to a limited amount)

IMPORTANT DISCLAIMER: I am NOT a registered investment adviser, broker dealer, or member of any other association for research providers in any jurisdiction whatsoever and I am NOT qualified to give financial advice. Investing/Trading in securities, particularly microcap securities, is highly speculative and carries and extremely high degree of risk. The information, analysis, and opinions listed above are my own and may not properly reflect the underlying conditions of a company or security. You should do your own Due Diligence. If you trade based on anything I have written YOU ACCEPT FULL RESPONSIBILITY AND LIABILITY for your own trades and actions and hold the author of this publication harmless. If that isn’t clear enough DO NOT TRADE, ACT, OR INVEST, BASED UPON ANYTHING I WRITE OR RECOMMEND. There, we should be solid now.

1 Comments on “04/12/2021 Pre Market Brief: Weekend News Edition”

  1. Pingback: 04/13/2021 Pre Market Brief: News While The Market Was Closed - MOON GANG CAPITAL

Leave a Reply